Global IVD (In Vitro Diagnostics) Market Size study , by Technology (Polymerase chain reaction, Next-generation Sequencing, Enzyme-Linked Immunosorbent Assay (ELISA), Rapid/PoC Tests, Hematology, Urinalysis and Others), by End-Users (Hospital-based Laboratories, Researchers & Academia, Reference Laboratories and Others), by Applications (Automotive, Building & Construction, Industrial Manufacturing, Polymer Modification, Wire & Cable, and Others) and Regional Forecasts 2020-2026

  • Product Code:
    RP-ID-10324806
  • Published Date:
    26 Jun 2020
  • Region:
    Global
  • Pages:
    200
  • Category:
    Healthcare & Pharmaceuticals
  • Publisher:
    Pub-ID-14

Impact Analysis on the Growth of Market

Activating Probable Propositions Amidst COVID-19 Crisis

With things going haywire, we analyze key points to make sure that the businesses around the globe are completely prepared to tackle potential implications caused by COVID-19. Be it protecting employees, customers or the overall business operations, we ensure that the employers take the right decisions, make strategic investments and maintain a healthy work culture along with taking probable measures to minimize the financial loss. Know More

Global IVD (In Vitro Diagnostics) Market is valued approximately USD XX million in 2019 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2019-2026. The demand for in-vitro diagnostic products due to the COVID-19 pandemic is expected to grow mainly due to factors such as a strong increase in the demand for PCR, NGS, serology-based rapid-test drugs, the favorable regulatory environment for drug creation & marketing and a sharp increase in target patient population. These trends have driven industry players to develop and enhance their existing capacities in production and delivery, as well as emphasis on commodity development & improvements. It is anticipated that the development of automated in vitro diagnostic (IVD) systems for laboratories and hospitals to provide reliable, precise, and error-free diagnosis would drive progress. For example, Becton, Dickinson and Company obtained CE-IVD certification for an integrated flow cytometry program from BD FACSDuet in March 2019 that helps clinical laboratories to improve their efficiency and performance in relation to manual processes. The growing geriatric population is projected to be one of the demand drivers for high impact rendering. According to the United Nations (UN), it has been estimated that there were about 962 million people worldwide with age over 60 in 2017. In fact, according to the World Health Organisation (WHO), by 2020, the number of people over 60 years would surpass that of children under 5 years of age. It is expected that the IVD industry will be powered by the involvement of research organizations that offer consultancy services, clinical tests, and laboratory testing to address the increasing need for fast diagnosis and treatment plans. For starters, NAMSA began IVD production company in July 2018 to provide global manufacturers with services such as regulatory in vitro diagnostics, and clinical testing.

The regional analysis of IVD (In Vitro Diagnostics) market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. In terms of value, the North America is expected to account for the majority of the market owing to the favorable government legislation, well-established healthcare infrastructure, in-vitro diagnostic technical advancements and the involvement of key market players are the factors responsible for the largest regional share.

Major market player included in this report are:
Siemens Healthineers AG
QIAGEN
Becton, Dickinson and Company
F. Hoffmann-La Roche Ltd.
bioMerieux SA
bioMerieux SA
Abbott Laboratories
Danaher
Sysmex Corporation
Cepheid
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Technology:
Polymerase chain reaction
Next-generation Sequencing
Enzyme-Linked Immunosorbent Assay (ELISA)
Rapid/PoC Tests
Hematology
Urinalysis
Others
By End-User:
Hospital-based Laboratories
Researchers & Academia
Reference Laboratories
Others
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017, 2018
Base year – 20198
Forecast period – 2020 to 2026

Target Audience of the Global IVD (In Vitro Diagnostics) Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Billion)
1.2.1. Global IVD (In Vitro Diagnostics) Market, by Region, 2018-2026 (USD Billion)
1.2.2. Global IVD (In Vitro Diagnostics) Market, by Technology, 2018-2026 (USD Billion)
1.2.3. Global IVD (In Vitro Diagnostics) Market, by End-Users, 2018-2026 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global IVD (In Vitro Diagnostics) Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global IVD (In Vitro Diagnostics) Market Dynamics
3.1. Global IVD (In Vitro Diagnostics) Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global IVD (In Vitro Diagnostics) Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global IVD (In Vitro Diagnostics) Market, by Technology
5.1. Market Snapshot
5.2. Global IVD (In Vitro Diagnostics) Market by Technology, Performance - Potential Analysis
5.3. Global IVD (In Vitro Diagnostics) Market Estimates & Forecasts by Technology 2016-2026 (USD Billion)
5.4. Global IVD (In Vitro Diagnostics) Market, Sub Segment Analysis
5.4.1. Polymerase chain reaction
5.4.2. Next-generation Sequencing
5.4.3. Enzyme-Linked Immunosorbent Assay (ELISA)
5.4.4. Rapid/PoC Tests
5.4.5. Hematology
5.4.6. Urinalysis
5.4.7. Others
Chapter 6. Global IVD (In Vitro Diagnostics) Market, by End-Users
6.1. Market Snapshot
6.2. Global IVD (In Vitro Diagnostics) Market by End-Users, Performance - Potential Analysis
6.3. Global IVD (In Vitro Diagnostics) Market Estimates & Forecasts by End-Users 2016-2026 (USD Billion)
6.4. Global IVD (In Vitro Diagnostics) Market, Sub Segment Analysis
6.4.1. Hospital-based Laboratories
6.4.2. Researchers & Academia
6.4.3. Reference Laboratories
6.4.4. Others
Chapter 7. Global IVD (In Vitro Diagnostics) Market, Regional Analysis
7.1. Global IVD (In Vitro Diagnostics) Market, Regional Market Snapshot
7.2. North America Global IVD (In Vitro Diagnostics) Market
7.2.1. U.S. Global IVD (In Vitro Diagnostics) Market
7.2.1.1. Technology breakdown estimates & forecasts, 2016-2026
7.2.1.2. End-Users breakdown estimates & forecasts, 2016-2026
7.2.2. Canada Global IVD (In Vitro Diagnostics) Market
7.3. Europe Global IVD (In Vitro Diagnostics) Market Snapshot
7.3.1. U.K. Global IVD (In Vitro Diagnostics) Market
7.3.2. Germany Global IVD (In Vitro Diagnostics) Market
7.3.3. Rest of Europe Global IVD (In Vitro Diagnostics) Market
7.4. Asia-Pacific Global IVD (In Vitro Diagnostics) Market Snapshot
7.4.1. China Global IVD (In Vitro Diagnostics) Market
7.4.2. India Global IVD (In Vitro Diagnostics) Market
7.4.3. Japan Global IVD (In Vitro Diagnostics) Market
7.4.4. Rest of Asia Pacific Global IVD (In Vitro Diagnostics) Market
7.5. Latin America Global IVD (In Vitro Diagnostics) Market Snapshot
7.5.1. Brazil Global IVD (In Vitro Diagnostics) Market
7.5.2. Mexico Global IVD (In Vitro Diagnostics) Market
7.6. Rest of The World Global IVD (In Vitro Diagnostics) Market

Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Siemens Healthineers AG
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Technology Summary
8.2.1.5. Recent Developments
8.2.2. QIAGEN
8.2.3. Becton, Dickinson and Company
8.2.4. F. Hoffmann-La Roche Ltd.
8.2.5. bioMerieux SA
8.2.6. bioMerieux SA
8.2.7. Abbott Laboratories
8.2.8. Danaher
8.2.9. Sysmex Corporation
8.2.10. Cepheid
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report
Siemens Healthineers AG
QIAGEN
Becton, Dickinson and Company
F. Hoffmann-La Roche Ltd.
bioMerieux SA
bioMerieux SA
Abbott Laboratories
Danaher
Sysmex Corporation
Cepheid
Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports